UB Paderborn / Katalog / Suche / in CDI

Prior Aspirin Use and Outcomes in Acute Coronary Syndromes

Journal of the American College of Cardiology, 2010-10, Vol.56 (17), p.1376-1385

2010

Link zum Volltext

Verfügbarkeit prüfen

Potent P2Y12 Inhibitors in Men Versus Women

Journal of the American College of Cardiology, 2017-03, Vol.69 (12), p.1549-1559

2017

Link zum Volltext

Verfügbarkeit prüfen

Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling

Journal of the American College of Cardiology, 2016-09, Vol.68 (11), p.1169-1178

2016

Link zum Volltext

Verfügbarkeit prüfen

Coronary Stent Thrombosis With Vorapaxar Versus Placebo

Journal of the American College of Cardiology, 2014-12, Vol.64 (22), p.2309-2317

2014

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

Journal of the American College of Cardiology, 2007-06, Vol.49 (23), p.2249-2255

2007

Link zum Volltext

Verfügbarkeit prüfen

Reply

Journal of the American College of Cardiology, 2016, Vol.67 (25), p.3025-3026

2016

Link zum Volltext

Verfügbarkeit prüfen

Reply

Journal of the American College of Cardiology, 2016, Vol.68 (3), p.326-326

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of Intensive Lipid-Lowering Therapy on Mortality After Acute Coronary Syndrome (a Patient-Level Analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Trials)

The American journal of cardiology, 2007-10, Vol.100 (7), p.1047-1051

2007

Link zum Volltext

Verfügbarkeit prüfen

New Ischemic Stroke and Outcomes With Vorapaxar Versus Placebo

Journal of the American College of Cardiology, 2014-12, Vol.64 (22), p.2318-2326

2014

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome

Journal of the American College of Cardiology, 2016-02, Vol.67 (4), p.353-361

2016

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Ischemic Events with Ticagrelor in Diabetic Patients: From the PEGASUS-TIMI 54 Trial

Journal of the American College of Cardiology, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar

JACC. Cardiovascular interventions, 2016-10, Vol.9 (20), p.2157-2164

2016

Link zum Volltext

Verfügbarkeit prüfen

Association of Blood Glucose With Angiographic and Clinical Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction (from the CLARITY-TIMI-28 Study)

The American journal of cardiology, 2008-02, Vol.101 (3), p.303-307

2008

Link zum Volltext

Verfügbarkeit prüfen

Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation

Journal of the American College of Cardiology, 2014-08, Vol.64 (6), p.576-584

2014

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)

The American journal of cardiology, 2008-09, Vol.102 (5), p.552-558

2008

Link zum Volltext

Verfügbarkeit prüfen

A Risk Score for Predicting Coronary Artery Disease in Women With Angina Pectoris and Abnormal Stress Test Finding

The American journal of cardiology, 2013-03, Vol.111 (6), p.781-785

2013

Link zum Volltext

Verfügbarkeit prüfen

High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients—A Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) analysis

The American heart journal, 2008-05, Vol.155 (5), p.954-958

2008

Link zum Volltext

Verfügbarkeit prüfen

Seasonal Variation in Lipids in Patients Following Acute Coronary Syndrome on Fixed Doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study)

The American journal of cardiology, 2009-04, Vol.103 (8), p.1056-1060

2009

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction

Journal of the American College of Cardiology, 2013-05, Vol.61 (18), p.1853-1859

2013

Link zum Volltext

Verfügbarkeit prüfen

Distribution of Traditional and Novel Risk Factors and Their Relation to Subsequent Cardiovascular Events in Patients With Acute Coronary Syndromes (from the PROVE IT-TIMI 22 Trial)

The American journal of cardiology, 2010-03, Vol.105 (5), p.619-623

2010

Link zum Volltext

Verfügbarkeit prüfen

Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention

JACC. Cardiovascular interventions, 2014-06, Vol.7 (6), p.604-612

2014

Link zum Volltext

Verfügbarkeit prüfen

Concomitant Administration of Clopidogrel With Statins or Calcium-Channel Blockers

JACC. Cardiovascular interventions, 2013-12, Vol.6 (12), p.1275-1281

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A key process analysis of patient and program factors

The American heart journal, 2008-02, Vol.155 (2), p.290-297

2008

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients With ST-Segment Elevation Myocardial Infarction Also Treated With Clopidogrel

Journal of the American College of Cardiology, 2007-06, Vol.49 (23), p.2256-2263

2007

Link zum Volltext

Verfügbarkeit prüfen

An Invasive or Conservative Strategy in Patients With Diabetes Mellitus and Non–ST-Segment Elevation Acute Coronary Syndromes

Journal of the American College of Cardiology, 2012-07, Vol.60 (2), p.106-111

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Prior Aspirin Use and Outcomes in Acute Coronary Syndromes

Potent P2Y12 Inhibitors in Men Versus Women

Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling

Coronary Stent Thrombosis With Vorapaxar Versus Placebo

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

Reply

Reply

Effect of Intensive Lipid-Lowering Therapy on Mortality After Acute Coronary Syndrome (a Patient-Level Analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Trials)

New Ischemic Stroke and Outcomes With Vorapaxar Versus Placebo

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome

Reduction in Ischemic Events with Ticagrelor in Diabetic Patients: From the PEGASUS-TIMI 54 Trial

Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar

Association of Blood Glucose With Angiographic and Clinical Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction (from the CLARITY-TIMI-28 Study)

Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation

Outcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)

A Risk Score for Predicting Coronary Artery Disease in Women With Angina Pectoris and Abnormal Stress Test Finding

High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients—A Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) analysis

Seasonal Variation in Lipids in Patients Following Acute Coronary Syndrome on Fixed Doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study)

Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction

Distribution of Traditional and Novel Risk Factors and Their Relation to Subsequent Cardiovascular Events in Patients With Acute Coronary Syndromes (from the PROVE IT-TIMI 22 Trial)

Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention

Concomitant Administration of Clopidogrel With Statins or Calcium-Channel Blockers

Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A key process analysis of patient and program factors

Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients With ST-Segment Elevation Myocardial Infarction Also Treated With Clopidogrel

An Invasive or Conservative Strategy in Patients With Diabetes Mellitus and Non–ST-Segment Elevation Acute Coronary Syndromes

Suchergebnisse filtern